|
1）Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin. 2011; 61: 69-90
|
|
|
|
2）Hudson TJ, Anderson W, Artez A, et al. International network of cancer genome projects. Nature. 2010; 464: 993-8
|
|
|
|
|
|
3）Totoki Y, Tatsuno K, Yamamoto S, et al. High-resolution characterization of a hepatocellular carcinoma genome. Nat Genet. 2011; 43: 464-9
|
|
|
|
|
|
4）Li M, Zhao H, Zhang X, et al. Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma. Nat Genet. 2011; 43: 828-9
|
|
|
|
|
|
5）Fujimoto A, Totoki Y, Abe T, et al. Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators. Nat Genet. 2012; 44(7): 760-4
|
|
|
|
|
|
6）Sung WK, Zheng H, Li S, et al. Genome-wide survey of recurrent HBV integration in hepato-cellular carcinoma. Nat Genet 2012; 44(7): 765-9
|
|
|
|
|
|
7）Guichard C, Amaddeo G, Imbeaud S, et al. Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma. Nat Genet. 2012; 44: 694-8
|
|
|
|
|
|
8）Kumar V, Kato N, Urabe Y, et al. Genome-wide association study identifies a susceptibility locus for HCV-induced hepatocellular carcinoma. Nat Genet. 2011; 43: 455-8
|
|
|
|
|
|
9）Miki D, Ochi H, Hayes CN, et al. Variation in the DEPDC5 locus is associated with progression to hepatocellular carcinoma in chronic hepatitis C virus carriers. Nat Genet. 2011; 43: 797-800
|
|
|
|
|
|
10）Li Y, Tang ZY, Hou JX. Hepatocellular carcinoma: insight from animal models. Nat Rev Gastroenterol Hepatol. 2012; 9: 32-43
|
|
|
|
|